Public Meeting / RFIhighComment deadline: April 11, 2025
FDA Opens Docket on Hemp-Derived Vape Products: Request for Information on Safety and Labeling
Agency seeks data on cannabinoid concentrations, additives, and youth access in hemp vapes
Announced: February 10, 2025
FDA Docket: FDA-2025-N-0142
Federal Register: 90 Fed. Reg. 12847
CBDDelta-8 THCDelta-10 THCHHCOtherVape / Inhalable
Summary
In February 2025, FDA published a Request for Information (RFI) and opened a public docket (FDA-2025-N-0142) on hemp-derived vape products. The 90 Fed. Reg. 12847 publication invites comments from manufacturers, retailers, public health researchers, and consumers on safety, labeling, and youth access issues associated with hemp-derived vaporizer products containing CBD, delta-8 THC, delta-10 THC, HHC, and other cannabinoids.
Focus areas of the RFI:
- Analytical data on cannabinoid concentrations and product consistency
- Additive safety: vitamin E acetate, cutting agents, terpene concentrations
- Youth access patterns and age verification effectiveness
- Comparative risk data vs. nicotine vapes and traditional cannabis
- Labeling adequacy, including child-resistant packaging compliance
The comment deadline is April 11, 2025. Operators have a significant opportunity to shape FDA's regulatory framework for hemp vapes — this is the most important federal comment opportunity for the vape segment in years.
Deep-Dive Analysis
🔒
Federal Pulse-Plus Exclusive
Full analysis is available to Federal Pulse-Plus subscribers ($499/mo). Includes in-depth regulatory breakdown, risk assessment, and Bob Hoban's strategic recommendations.
What Operators Should Do Now
Comment deadline: April 11, 2025 — act now:
1. Submit a substantive comment to docket FDA-2025-N-0142 at regulations.gov. This is the highest-leverage federal advocacy opportunity for hemp vape operators in years.
2. Compile your safety data: batch testing results, additive analysis, third-party lab certifications, and age verification protocols.
3. Engage counsel to review your comment before filing — the administrative record is permanent and will be used in future rulemaking and enforcement proceedings.
4. Coordinate with industry associations (NCIA, Hemp Roundtable, etc.) to submit coordinated industry data.
5. Do not submit without legal review — incomplete, inaccurate, or inadvertently damaging disclosures in public comments create long-term regulatory risk.